Heery Christopher 4
4 · Arcellx, Inc. · Filed Sep 19, 2025
Insider Transaction Report
Form 4
Arcellx, Inc.ACLX
Heery Christopher
CHIEF MEDICAL OFFICER
Transactions
- Sale
Common Stock
2025-09-18$80.01/sh−3,343$267,468→ 34,427 total - Sale
Common Stock
2025-09-19$80.00/sh−300$24,000→ 34,127 total
Footnotes (3)
- [F1]The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 23, 2025.
- [F2]Represents the weighted average share price of an aggregate total of 3,343 shares sold in the price range of $80.00 to $80.055 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Includes 284 shares acquired under the Issuer's 2022 Employee Stock Purchase Plan on May 14, 2025.